Company Overview and News

0
Deals of the day-Mergers and acquisitions

2018-07-10 reuters
July 10 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:
MNLDF CHLKF PFD SFTBF CTTAF XRX MDL FUJIF YAHOF 0941 4901 CHL GTY 4689 CTTAY YAHOY 9984 FUJIY SFTBY CMBGF

19
UPDATE 1-Hometown America drops due diligence condition for Gateway Lifestyle offer

2018-07-02 reuters
(Reuters) - Hometown America adjusted its takeover bid for Australian retirement village owner Gateway Lifestyle Group (GTY.AX) on Monday, offering to drop due diligence if the target agreed to its A$695 million ($514 million) cash offer.
BAMGF GTY BAMKF BAM

19
Hometown America sweetens Gateway Lifestyle offer

2018-07-02 reuters
July 2 (Reuters) - Hometown America sweetened its takeover bid for Australian retirement village owner Gateway Lifestyle Group on Monday, offering to drop due diligence if the target agreed to its A$695 million ($514 million) cash offer.
BAMGF GTY BAMKF BAM

6
Deals of the day-Mergers and acquisitions

2018-06-25 reuters - 1
June 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2030 GMT on Monday:
XRM EDR EUTLF ETCMY TWX TWC GTN.A JCDXY GTN GTY APO DGE DGE DEO JCDXF

2
Deals of the day-Mergers and acquisitions

2018-06-25 reuters
June 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1130 GMT on Monday:
EDR XRM JCDXY GTY OML APO JCDXF

19
CANADA STOCKS-TSX futures fall on lower oil prices

2018-06-21 reuters
June 21 (Reuters) - Futures pointed to a lower opening for Canada’s main stock index on Thursday as oil prices fell on signs that OPEC is nearing a deal to bump up crude production.
BAMGF GTY BAMKF BAM

27
Deals of the day-Mergers and acquisitions

2018-06-21 reuters
June 21 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday: ** Czech soft drinks company Kofola Ceskoslovensko said it had acquired the Slovak mineral water company Klastorna, expanding its portfolio in central Europe. ** German reinsurer Munich Re is in talks to sell its asset management division to U.S. fund manager Guggenheim Partners, a person familiar with the matter said.
BAMGF AGODY MALRY MIN AGO GTY ATLGF CLNY MALRF APO BAMKF BAM

19
UPDATE 1-Australia's Gateway Lifestyle receives bid from Canada's Brookfield

2018-06-21 reuters
(Reuters) - Australia’s Gateway Lifestyle Group (GTY.AX) said on Thursday it had received a non-binding A$698.6 million ($514.7 million) offer from Canadian firm Brookfield Property Group, a unit of Brookfield Asset Management Inc (BAMa.TO).
BAMGF GTY BAMKF BAM

42
Deals of the day-Mergers and acquisitions

2018-06-13 reuters
June 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:
MNLDF BGX GTY TWX BGLF BX IOF TWC APA MDL BGB

Related Articles

REPH: Recro Pharma Analysis and Research Report

20h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

21h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...